Recently, an in vitro study showed that AR increases haematogenous metastasis but decreases lymphatic metastasis of RCC by enhancing miR‐185‐5p expression, which promoted HIF2α/VEGF‐A and suppressed VEGF‐C expression.47 This evidence concerns the gene AR and renal cell carcinoma.